NCT00625157View on ClinicalTrials.gov

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Discoid Lupus Erythematosus

Interventions

DRUG

ASF 1096 0.5 % cream

DRUG

ASF 1096 placebo cream

Trial Locations (1)

Unknown

Gregor Jemec, Roskilde Hospital

Sponsors

Lead Sponsor

Astion Pharma A/S

All Listed Sponsors

lead

Astion Pharma A/S

INDUSTRY

NCT00625157 - Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) | Biotech Hunter | Biotech Hunter